ZNF295 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.32139904258133E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.61841999999357E-05 |
Normal-vs-Stage2 |
4.14520000002749E-06 |
Normal-vs-Stage3 |
3.26639826297992E-11 |
Normal-vs-Stage4 |
3.79474229816879E-13 |
Stage1-vs-Stage2 |
2.309600E-01 |
Stage1-vs-Stage3 |
8.031900E-04 |
Stage1-vs-Stage4 |
2.0619999996363E-07 |
Stage2-vs-Stage3 |
2.402200E-01 |
Stage2-vs-Stage4 |
1.647770E-02 |
Stage3-vs-Stage4 |
1.113210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.57809987300084E-10 |
Normal-vs-AfricanAmerican |
4.96739999999996E-06 |
Normal-vs-Asian |
8.761900E-03 |
Caucasian-vs-AfricanAmerican |
7.404400E-01 |
Caucasian-vs-Asian |
5.789600E-01 |
AfricanAmerican-vs-Asian |
7.045800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.98041583132635E-12 |
Normal-vs-Female |
2.35390000002944E-06 |
Male-vs-Female |
2.086100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.83290000002712E-06 |
Normal-vs-Age(41-60Yrs) |
1.65610000157912E-08 |
Normal-vs-Age(61-80Yrs) |
1.10120024210403E-10 |
Normal-vs-Age(81-100Yrs) |
6.059900E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.392830E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.912600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.929840E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.943400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.412600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.427200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.249600E-01 |
Normal-vs-Grade 2 |
2.4151999999944E-05 |
Normal-vs-Grade 3 |
2.89779311657412E-12 |
Normal-vs-Grade 4 |
1.72084568816899E-14 |
Grade 1-vs-Grade 2 |
3.177400E-01 |
Grade 1-vs-Grade 3 |
1.391970E-02 |
Grade 1-vs-Grade 4 |
1.740120E-02 |
Grade 2-vs-Grade 3 |
2.183300E-04 |
Grade 2-vs-Grade 4 |
1.67909997017546E-09 |
Grade 3-vs-Grade 4 |
3.703800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.737300E-03 |
Normal-vs-ccB subtype |
2.57449617180328E-11 |
ccA subtype-vs-ccB subtype |
6.2035000025773E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.79460010688126E-10 |
Normal-vs-N1 |
2.04520000046671E-07 |
N0-vs-N1 |
8.368400E-02 |
|
|